fbpx
QQQ
+ 1.31
311.52
+ 0.42%
DIA
-5.22
319.22
-1.66%
SPY
-2.36
384.73
-0.62%
TLT
+ 4.58
133.96
+ 3.31%
GLD
-4.03
169.90
-2.43%

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash

by
January 7, 2013 3:17 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash

Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash.

Salix Pharmaceuticals (NASDAQ: SLXP) had $775.90 million in total cash and $869.10 million in total debt for the latest quarter.

Mylan (NASDAQ: MYL) had $412.67 million in total cash for the latest quarter. However, Mylan had $5.37 billion in total debt for the same period.

Hi Tech Pharmacal Co (NASDAQ: HITK) had $104.09 million in total cash and $1.42 million in total debt for the latest quarter.

Akorn (NASDAQ: AKRX) had $38.40 million in total cash and $103.65 million in total debt for the latest quarter.

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted-In:

Trading Ideas

Related Articles

33 Stocks Moving in Wednesday's Pre-Market Session

Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) shares rose 47.8% to $1.22 in pre-market trading after jumping over 33% on Tuesday. read more

96 Biggest Movers From Yesterday

Gainers Mmtec, Inc. (NASDAQ: MTC) shares climbed 86.4% to close at $2.05 on Tuesday after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019. read more

61 Stocks Moving In Tuesday's Mid-Day Session

Gainers Mmtec, Inc. (NASDAQ: MTC) shares jumped 98.2% to $2.18 in pre-market trading after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797, in 2019. read more

28 Stocks Moving in Tuesday's Pre-Market Session

Gainers Mmtec, Inc. (NASDAQ: MTC) shares rose 77.2% to $1.95 in pre-market trading after reporting its financial results for the year ended December 31, 2019. Revenues jumped 647% to $200,797,in 2019. read more